Eli Lilly and Company (LLY)
Symbol Info
Listed Symbol LLY
Name Eli Lilly and Company
Share Info
Annual Info
Latest Fiscal Dividend Per Share $2.25
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $24,555,700,000
Latest Fiscal EPS $3.13
Price Info
21 Day Moving Average $111.7929
21 Day EMA $111.772370
50 Day Moving Average $110.5592
50 Day EMA $111.767320
200 Day EMA $111.555030
200 Day Moving Average 115.515030
52 Week High $132.13
52 Week Low $104.17
52 Week Change $6.316600
Alpha 0.011128
Beta 0.1571
Standard Deviation 0.049803
R2 0.011820
Periods 60
Share Information
10 Day Average Volume 3,860,957
20 Day Average Volume 3,248,349
30 Day Average Volume 3,617,399
50 Day Average Volume 3,777,805
Outstanding Shares 965,432,952
Float Shares 961,356,619
Percent Float 99.58%
Short Interest 14,161,063
Short Percent Float 1.50%
Short Interest Ratio 3.95
Short Date 2019-08-30
Holders
Institutions 2,507
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 101,525,399
Institute Holdings Percent -
Institute Sold Previous 3 Months 111,533,295
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 4,076,333
Price Change
7 Day Price Change $-3.1600037
7 Day Percent Change -2.77%
21 Day Price Change $1.3799973
21 Day Percent Change 1.26%
30 Day Price Change $-4.1649704
30 Day Percent Change -3.62%
Month To Date Price Change $-2.08
Month To Date Percent -1.84%
90 Day Price Change $-0.306602
90 Day Percent Change -0.28%
Quarter To Date $0.717651
Quarter To Date Percent 0.65%
180 Day Price Change $-13.8964
180 Day Percent Change -11.14%
200 Day Price Change $-11.621986
200 Day Percent Change -9.49%
Year To Date $-2.925949
Year To Date Percent -2.57%
Profile
Description Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.
Details
Issue Type CS
Market Cap $107,056,860,047
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 965,432,952
CEO David A. Ricks
Employees 38,680
Last Audit UE
Classification
CIK 0000059478
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address Lilly Corporate Center
Indianapolis, IN 46285
Website http://www.lilly.com
Facisimile
Telephone +1 317 276-2000
Email hern_kevin_r@lilly.com
Key Ratios
Profitability
EBIT Margin 19.90
EBITDA Margin 25.4
Pre-Tax Profit Margin 14.0
Profit Margin Cont 17.91
Gross Margin 74.60
Profit Margin TOT 33.93
Income Statements
Revenue $23,229,400,000
Revenue Per Share $24.0611
Revenue 3 Years $4.53
Revenue 5 Years $3.88
Valuation Measures
PE Ratio 14.00
Enterprise Value $121,538,411,159
Price To Sales 4.608680
Price To Free Cash -18
PE High Last 5 Years -
Price To Book 38.7
Price To Cash Flow 22.4
PE Low Last 5 Years -
Price To Tangible Book -14.1
Financial Strength
Total Debt To Equity 5.9
Int Coverage 14.3
Current Ratio 1.1
Leverage Ratio 5.9
Quick Ratio 0.7
Long Term Debt To Capital 0.84
Assets
Receivables Turnover 4.3
Invoice Turnover 1.70
Assets Turnover 0.60
Management Effectiveness
Return Assets 19.22
Return On Equity 108.18
Return On Capital 37.55
Dividends
Dividend 3 Years $4.72
Dividend 5 Years $3.36
Ex Dividend Date 2019-08-14 00:00:00.0
Dividend Rate $2.58
Dividend Yield 2.33%
Payment Type Cash
Your Recent History
NYSE
LLY
Eli Lilly
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190915 22:34:24